Invention Grant
- Patent Title: Compounds
-
Application No.: US17288225Application Date: 2019-10-23
-
Publication No.: US12180210B2Publication Date: 2024-12-31
- Inventor: Peng Li , Hailin Zheng
- Applicant: INTRA-CELLULAR THERAPIES, INC.
- Applicant Address: US NY New York
- Assignee: INTRA-CELLULAR THERAPIES, INC.
- Current Assignee: INTRA-CELLULAR THERAPIES, INC.
- Current Assignee Address: US NY New York
- Agency: Hoxie & Associates LLC
- International Application: PCT/US2019/057549 WO 20191023
- International Announcement: WO2020/086650 WO 20200430
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61P25/00
Abstract:
The present disclosure relates to novel PDE2 inhibitory compounds of Formula I as described herein, their use as pharmaceuticals and pharmaceutical compositions comprising them.
Public/Granted literature
- US20220064169A1 NOVEL COMPOUNDS Public/Granted day:2022-03-03
Information query
